Inspection Record

Professional Partners Inc./ Westcliff Compounding Pharmacy — FDA 483 Findings

US FDAInspected 2016-06-06Published 2024-01-17 8 findingsAseptic processing and sterility assuranceStability and storageEquipment and facilityDeviation, CAPA, and investigationLaboratory and QC controls

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile do not include adequate validation of the sterilization process.

2Stability and storage

There is no written testing program designed to assess the stability characteristics of drug products.

3Aseptic processing and sterility assurance

Drug product containers and closures were not clean and sterilized and processed to remove pyrogenic properties to assure that they are suitable for their intended use.

4Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.

5Equipment and facility

Written procedures are not followed for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.

6Equipment and facility

The calibration of instruments, apparatus and recording devices is not done at suitable intervals in accordance with an established written program.

7Deviation, CAPA, and investigation

Written records are not always made of investigations into unexplained discrepancies and the failure of a batch or any of its components to meet specifications.

8Laboratory and QC controls

Each batch of drug product required to be free of objectionable microorganisms is not tested through appropriate laboratory testing.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Professional Partners Inc./ Westcliff Compounding Pharmacy company profile — full history US FDA documents, 2024 Go to Findings search